Globeflex Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.58M | Buy |
28,457
+6,255
| +28% | +$786K | 0.3% | 78 |
|
|
2025
Q1 | $2.46M | Sell |
22,202
-1,202
| -5% | -$133K | 0.23% | 94 |
|
|
2024
Q4 | $3.19M | Buy |
23,404
+1,202
| +5% | +$164K | 0.27% | 87 |
|
|
2024
Q3 | $2.56M | Buy |
22,202
+703
| +3% | +$81K | 0.25% | 93 |
|
|
2024
Q2 | $2.96M | Sell |
21,499
-1,437
| -6% | -$198K | 0.31% | 73 |
|
|
2024
Q1 | $3.16M | Hold |
22,936
| – | – | 0.31% | 75 |
|
|
2023
Q4 | $3.02M | Buy |
22,936
+1,781
| +8% | +$235K | 0.31% | 80 |
|
|
2023
Q3 | $2.38M | Hold |
21,155
| – | – | 0.28% | 97 |
|
|
2023
Q2 | $1.99M | Sell |
21,155
-3,911
| -16% | -$369K | 0.22% | 116 |
|
|
2023
Q1 | $2.54M | Buy |
25,066
+7,828
| +45% | +$792K | 0.31% | 90 |
|
|
2022
Q4 | $2.06M | Buy |
17,238
+5,708
| +50% | +$682K | 0.26% | 97 |
|
|
2022
Q3 | $1.23M | Buy |
+11,530
| New | +$1.23M | 0.21% | 147 |
|
|
2020
Q4 | – | Sell |
-5,632
| Closed | -$542K | – | 505 |
|
|
2020
Q3 | $542K | Sell |
5,632
-999
| -15% | -$96.1K | 0.14% | 237 |
|
|
2020
Q2 | $809K | Sell |
6,631
-2,637
| -28% | -$322K | 0.21% | 168 |
|
|
2020
Q1 | $802K | Hold |
9,268
| – | – | 0.25% | 144 |
|
|
2019
Q4 | $996K | Buy |
+9,268
| New | +$996K | 0.19% | 192 |
|
|
2015
Q4 | – | Sell |
-20,400
| Closed | -$812K | – | 485 |
|
|
2015
Q3 | $812K | Sell |
20,400
-4,000
| -16% | -$159K | 0.17% | 211 |
|
|
2015
Q2 | $1.17M | Buy |
+24,400
| New | +$1.17M | 0.21% | 178 |
|